pentobarbital has been researched along with Malignant Hypertension in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OLMER, J | 1 |
| CARCASSONNE, Y | 1 |
| Miura, Y | 1 |
2 other studies available for pentobarbital and Malignant Hypertension
| Article | Year |
|---|---|
[MALIGNANT ARTERIAL HYPERTENSION: PROLONGED EFFECTS OF SLEEP THERAPY].
Topics: Chlorpromazine; Hypertension; Hypertension, Malignant; Pentobarbital; Promethazine; Sleep | 1964 |
Improved method for measurement of renin activity in human plasma.
Topics: Angiotensin II; Animals; Biological Assay; Blood Pressure; Chromatography; Edetic Acid; Female; Huma | 1969 |